TiGenix, the Glossary
TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell (eASC) platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product.[1]
Table of Contents
12 relations: Belgium, Biotechnology, Crohn's disease, Eduardo Bravo, Euronext, Ghent University, KU Leuven, Leuven, Public company, Research spin-off, Takeda Pharmaceutical Company, The Lancet.
- 2000 establishments in Belgium
- Biotechnology companies of Belgium
- Companies based in Leuven
- Pharmaceutical companies disestablished in 2018
- Pharmaceutical companies established in 2000
Belgium
Belgium, officially the Kingdom of Belgium, is a country in Northwestern Europe.
Biotechnology
Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services.
Crohn's disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any segment of the gastrointestinal tract.
See TiGenix and Crohn's disease
Eduardo Bravo
Eduardo Bravo Ávila (born 18 February 1991) is a Mexican professional footballer who plays as a goalkeeper.
Euronext
Euronext N.V. (short for European New Exchange Technology) is a pan-European bourse that provides trading and post-trade services for a range of financial instruments.
Ghent University
Ghent University (Universiteit Gent, abbreviated as UGent) is a public research university located in Ghent, Belgium.
See TiGenix and Ghent University
KU Leuven
KU Leuven (Katholieke Universiteit Leuven) is a Catholic research university in the city of Leuven, Belgium.
Leuven
Leuven, also called Louvain (Löwen), is the capital and largest city of the province of Flemish Brabant in the Flemish Region of Belgium.
Public company
A public company is a company whose ownership is organized via shares of stock which are intended to be freely traded on a stock exchange or in over-the-counter markets.
See TiGenix and Public company
Research spin-off
A research spin-off is a company that falls into at least one of the four following categories.
See TiGenix and Research spin-off
Takeda Pharmaceutical Company
The is a Japanese multinational pharmaceutical company.
See TiGenix and Takeda Pharmaceutical Company
The Lancet
The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind.
See also
2000 establishments in Belgium
- Artevelde University of Applied Sciences
- Baloise–Trek Lions
- British International School of Brussels
- Clockarium
- De Vlaamse Trofee Deschacht
- EUobserver
- Federal Agency for the Safety of the Food Chain
- GP Mario De Clercq
- Grand Prix Sven Nys
- Johanniter International
- Pantheist (band)
- Plopsaland De Panne
- Republican Circle
- TiGenix
- Transnational University Limburg
- VTM 3
- Wonder en is gheen Wonder
- Zinneke Parade
Biotechnology companies of Belgium
- Ablynx
- Applied Maths
- Citrique Belge
- CropDesign
- DevGen
- Eurogentec
- Innogenetics
- Plant Genetic Systems
- Steakholder Foods
- TiGenix
Companies based in Leuven
- AB InBev
- Belgian Beer Café
- Crescent (Belgian company)
- IMEC
- InBev
- Interbrew
- Intermodalics
- Luciad
- Materialise NV
- Septentrio
- TiGenix
Pharmaceutical companies disestablished in 2018
- Bioverativ
- Farm Fresh Food & Pharmacy
- TiGenix
Pharmaceutical companies established in 2000
- Chemist Warehouse
- Concord Biotech
- CureVac
- GSK plc
- Guizhentang Pharmaceutical Company
- Melinta Therapeutics
- Merrimack Pharmaceuticals
- Ovation Pharmaceuticals
- Renovo plc
- Sino Biopharmaceutical Limited
- TiGenix
- Tolerx
- WuXi AppTec